Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Context: The use of prostate specific antigen (PSA) screening for prostate cancer is controversial because of a lack of evidence that such screening saves lives when applied within a population and because such testing can lead to invasive downstream biopsies and aggressive treatment that is associated with a high risk of permanent side effects (e.g. impotence, incontinence). Almost all professional societies (American Cancer Society, American Urologic Association, American College of Physicians, United States Preventive Services Task Force) advocate that patients receive education and complete an informed decision-making discussion with their medical providers about the pros and cons of the PSA test, as well as their personal preferences, before proceeding with this test. Unfortunately, despite these recommendations, there is seldom sufficient time during clinic visits to achieve this goal.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PSA flyer | Experimental |
| |
| Control | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PSA flyer | Other | A mailed low-literacy informational patient flyer about the PSA test |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of PSA testing | Rate of PSA testing will be determined by reviewing the chart of enrolled patients within two weeks of their annual physical | At the time of the annual exam (within two weeks of their annual physical) |
| Rate of documented PSA discussions | Rate of documented PSA discussions will be determined through chart review within two weeks of the annual physical. | At the time of the annual exam (within two weeks of their annual physical) |
| Measure | Description | Time Frame |
|---|---|---|
| Flyer acceptability | The acceptability of the flyer will be assessed through a follow-up phone interview of patients who had received the flyer. | Within two weeks of the annual exam |
| Perceived participation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Hospital | Aurora | Colorado | 80045 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Perceived participation will be assessed in a follow-up phone interview within two weeks of the annual physical using validated measures of particiption in decision making.
| Within two weeks |
| Prostate Cancer Screening knowledge | Prostate cancer screening knowledge will be assessed using 5 knowledge questions surrounding PSA testing during a follow-up interview 2 weeks after the annual physical | Within two weeks |